Document is current

442-J Anti-AXL CAR-NK cell immunotherapy to target BRAF inhibitor drug-resistant and metastatic melanoma

Crossref DOI link: https://doi.org/10.1136/jitc-2023-SITC2023.0442-J

Published Online: 2023-10-31

Published Print: 2023-11

Update policy: https://doi.org/10.1136/crossmarkpolicy